MCKENZIE DIANA has filed 42 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 721 shares of METLIFE INC ($MET) on April 01, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 721 | $71.17 | 24,472.0000 | 673,300,000 | 3.04% | 0.00% |
| March 10, 2026 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 189 | $70.60 | 23,751.0000 | 673,300,000 | 0.80% | 0.00% |
| Jan. 2, 2026 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 639 | $80.32 | 23,562.0000 | 673,300,000 | 2.79% | 0.00% |
| Dec. 9, 2025 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 166 | $77.82 | 22,923.0000 | 677,000,000 | 0.73% | 0.00% |
| Oct. 1, 2025 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 534 | $81.93 | 22,757.0000 | 677,000,000 | 2.40% | 0.00% |
| Sept. 9, 2025 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 158 | $79.29 | 22,223.0000 | 711,100,000 | 0.72% | 0.00% |
| June 17, 2025 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 562 | $77.85 | 22,065.0000 | 711,100,000 | 2.61% | 0.00% |
| June 10, 2025 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 153 | $79.43 | 21,503.0000 | 711,100,000 | 0.72% | 0.00% |
| May 28, 2025 | agilon health, inc. | $AGL | MCKENZIE DIANA | Director | A | Common Stock | 78724 | $0.00 | 137,543.0000 | 412,303,066 | 133.84% | 0.02% |
| May 1, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | MCKENZIE DIANA | Director | A | Deferred Stock Units | 1001 | $0.00 | 6,991.4830 | 257,899,999 | 16.71% | 0.00% |
| May 1, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | MCKENZIE DIANA | Director | D | Common Stock | 1001 | $0.00 | 2,438.0000 | 257,899,999 | 29.11% | 0.00% |
| May 1, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | MCKENZIE DIANA | Director | A | Common Stock | 796 | $0.00 | 3,439.0000 | 257,899,999 | 30.12% | 0.00% |
| April 1, 2025 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 540 | $81.16 | 21,350.0000 | 711,100,000 | 2.59% | 0.00% |
| March 11, 2025 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 144 | $78.45 | 20,810.0000 | 711,100,000 | 0.70% | 0.00% |
| Jan. 2, 2025 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 535 | $81.78 | 20,667.0000 | 711,100,000 | 2.66% | 0.00% |
| Dec. 16, 2024 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 132 | $82.74 | 20,132.0000 | 715,500,000 | 0.66% | 0.00% |
| Nov. 25, 2024 | agilon health, inc. | $AGL | MCKENZIE DIANA | Director | P | Common Stock | 12500 | $2.28 | 51,319.0000 | 0 | 32.20% | 0.00% |
| Dec. 9, 2024 | agilon health, inc. | $AGL | MCKENZIE DIANA | Director | P | Common Stock | 7500 | $2.20 | 58,819.0000 | 0 | 14.61% | 0.00% |
| Oct. 1, 2024 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 535 | $81.78 | 20,000.0000 | 715,500,000 | 2.75% | 0.00% |
| Sept. 10, 2024 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 141 | $74.63 | 19,465.0000 | 762,300,000 | 0.73% | 0.00% |
| June 18, 2024 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 627 | $69.86 | 19,324.0000 | 762,300,000 | 3.35% | 0.00% |
| June 11, 2024 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 146 | $69.06 | 18,697.0000 | 762,300,000 | 0.79% | 0.00% |
| May 29, 2024 | agilon health, inc. | $AGL | MCKENZIE DIANA | Director | A | Common Stock | 32119 | $0.00 | 38,819.0000 | 0 | 479.39% | 0.00% |
| May 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | MCKENZIE DIANA | Director | A | Deferred Stock Units | 1168 | $0.00 | 5,990.4830 | 260,500,000 | 24.22% | 0.00% |
| May 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | MCKENZIE DIANA | Director | A | Common Stock | 1001 | $0.00 | 3,811.0000 | 260,500,000 | 35.62% | 0.00% |
| May 1, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | MCKENZIE DIANA | Director | D | Common Stock | 1168 | $0.00 | 2,643.0000 | 260,500,000 | 30.65% | 0.00% |
| April 1, 2024 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 594 | $73.69 | 18,550.0000 | 762,300,000 | 3.31% | 0.00% |
| March 14, 2024 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 129 | $71.90 | 17,956.0000 | 762,300,000 | 0.72% | 0.00% |
| Jan. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | MCKENZIE DIANA | Director | A | Deferred Stock Units | 77 | $432.99 | 4,822.4830 | 260,500,000 | 1.61% | 0.00% |
| Jan. 2, 2024 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 650 | $67.35 | 17,828.0000 | 762,300,000 | 3.78% | 0.00% |
| Dec. 14, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 132 | $66.90 | 17,178.0000 | 808,900,000 | 0.77% | 0.00% |
| Oct. 2, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 710 | $61.69 | 17,045.0000 | 808,900,000 | 4.35% | 0.00% |
| Sept. 14, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 128 | $65.93 | 16,335.0000 | 808,900,000 | 0.79% | 0.00% |
| June 20, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 803 | $54.52 | 16,207.0000 | 808,900,000 | 5.21% | 0.00% |
| June 14, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 147 | $53.94 | 15,404.0000 | 808,900,000 | 0.96% | 0.00% |
| April 14, 2023 | agilon health, inc. | $AGL | MCKENZIE DIANA | Director | A | Common Stock | 5622 | $0.00 | 6,700.0000 | 0 | 521.52% | 0.00% |
| April 3, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 755 | $57.97 | 15,257.0000 | 808,900,000 | 5.21% | 0.00% |
| March 14, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 121 | $59.07 | 14,502.0000 | 808,900,000 | 0.84% | 0.00% |
| Feb. 28, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 31 | $71.73 | 14,381.0000 | 808,900,000 | 0.22% | 0.00% |
| Feb. 17, 2023 | agilon health, inc. | $AGL | MCKENZIE DIANA | Director | A | Common Stock | 1078 | $0.00 | 1,078.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | agilon health, inc. | $AGL | MCKENZIE DIANA | Director | A | Options (Rights to Buy) | 11104 | $0.00 | 11,104.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | METLIFE INC | $MET | MCKENZIE DIANA | Director | A | Common Stock | 520 | $72.15 | 14,350.0000 | 808,900,000 | 3.76% | 0.00% |